Journal article
The dilution of benzalkonium chloride (BAK) in the tear Film
Abstract
The claim that benzalkonium chloride (BAK) synergistically enhances the antibiotic efficacy of gatifloxacin ophthalmic solution 0.3% (preserved with 0.005% BAK [50 μg/mL), Zymar; Allergan Inc., Irvine, Calif, USA) has been the subject of several studies. The purpose of this prospective clinical study was to test the hypothesis that BAK would be significantly diluted shortly after topical ocular administration and would thereafter have little or …
Authors
Friedlaender MH; Breshears D; Amoozgar B; Sheardown H; Senchyna M
Journal
Advances in Therapy, Vol. 23, No. 6, pp. 835–841
Publisher
Springer Nature
Publication Date
November 2006
DOI
10.1007/bf02850204
ISSN
0741-238X